Sectors

 

Laboratory Diagnostics

With both winners and losers as a result of Covid-19, we’ll review the current status of the diagnostic lab market. As we look ahead and anticipate revenues to fall back in line with pre-Covid levels, what is the investor viewpoint? What strategies are operators employing to manage profitability and drive growth? How fast are sub-sectors […]

It’s all about the Patient Experience…

Digitalisation has forced a paradigm shift in the meaning of ‘patient experience’. In a blended model of face-to-face and hybrid interactions and care plans – how to research, manage and measure customer experience needs a rethink; how to engage, communicate and build loyalty needs a reset. With more touchpoints, now is the time to unlock […]

Unlocking the Potential of Integrated Care Chains

Moving from isolated episodes of care to care continuum enables operators to maximise customer value and scale businesses. In this session we’ll be exploring care chains, how to optimise chains vs assets, the role of digital in enabling this transformation,  and how digital will unlock value through automation and efficiency. Speakers include: Peter Wharton-Hood, Group […]

Elderly Care

Growth projections have always been difficult in the elderly care sector – and now even challenged as a result of Covid-19. Our panel of experts representing nursing homes, assisted living and domiciliary care share their views on the opportunities and challenges as we look ahead to the next 3 years. Speakers include: Marc Saillon, CEO, […]

Imaging and Radiotherapy

These closely related sectors are seeing a huge M&A boom as investors seek to consolidate rich west Europe (DACH, France and Northern Italy). Other players such as Affidea with its platform in 15 countries are also for sale. So what is the attraction? And how far is it possible to build an ecosystem of outpatient clinics […]

Fertility

The fertility sector continues on a steady trajectory of growth across Europe, with growing demand and disposable income. However as a fragmented marketplace, consolidation as a route to achieve scale is not straightforward. In this session we’ll explore different scenarios for growth and hear from investors and operators about what they’re most excited about. Speakers […]

Ophthalmology

Ophthalmology continues to be a big area of investor interest with considerable scope for consolidation. Governments are increasingly outsourcing cataract operations and the sector is starting to unlock the potential for multifocal lens in middle age.  We’ll explore how businesses are increasing their value in the drive for profit growth. Speakers include: Tim Clover, CEO, […]

Rutherford Health to go into liquidation

The for-profit oncology group which holds roughly half the UK's proton beam capacity and has invested over £240m in capex is to go into liquidation, thanks to the pandemic and NHS indifference. In the UK just 1% of acute cancer patients get proton compared to 10% in Europe and 20% in the USA. What is likely to happen next?

Fresenius Helios launches revolutionary primary care offer

Fresenius Helios plans to become the first and only global health care service player by rolling out its Curalie telehealth plus a prefab diagnostic unit (the Cube) starting in Vietnam in October. Deals are being struck with governments in Ghana and Kenya for the group to offer primary care for €10 per cap. to millions. We talk to Fresenius Helios CEO Franceso de Meo.

Interview: Dagmar Dvorakova, CEO and Prof. Dr. Roland Staudinger, managing director, Aquilia Health Group

Smart reha, medical malls, how to best deploy new medtech, Fresenius Vamed veterans both, Dagmar and Roland are full of ideas on how to best build and run health care service models from acute hospitals to rehab and outpatient. Two and a half years ago they quit the mothership to set up Aquila which now employs 45 and runs projects in China, SE Asia, Austria, Germany and the Czech Rep.

Find Us